23:15 18/02/2017 Pfizer Near A Technical Breakout
Pfizer Near A Technical Breakout
Seeking Alpha - 12 hours ago
Pfizer's share price won't go to the moon but I believe there is strong downside protection here mainly due to the company's sheer size and diversification. I think what dividend investors need to take into account here is that there are companies ...
Pfizer Inc. (PFE) Closes Flat on the Day for February 17 - Equities.com
Taking a Fresh Look at Pfizer Inc. (PFE) - StockNewsJournal

16:41 18/02/2017 Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.
Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.
Madison.com - 19 hours ago
Pfizer's prospects have improved for several reasons. Several products in the company's current lineup are performing exceptionally well.

21:45 13/02/2017 BRIEF-Pfizer Inc reports 16.4 pct stake in ICU Medical
BRIEF-Pfizer Inc reports 16.4 pct stake in ICU Medical
Reuters - Feb 13, 2017
Feb 13 ICU Medical Inc : * Pfizer Inc reports 16.4 pct stake in ICU Medical Inc as of Feb. 3 Source text: (bit.ly/2kpY8il) Further company coverage: Next In Market News.

19:16 09/02/2017 Pfizer Inc.: Invest For Attractive Valuation And The 4% Dividend Yield
Pfizer Inc.: Invest For Attractive Valuation And The 4% Dividend Yield
Seeking Alpha - Feb 9, 2017
Pfizer Inc. (NYSE:PFE) is one of the world's largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.

16:07 09/02/2017 Pfizer: Another Reason To Stay Long
Pfizer: Another Reason To Stay Long
Seeking Alpha - Feb 9, 2017
There were already plenty of reasons like Pfizer (NYSE:PFE) as a long-term investment but management just gave investors another reason to add to that list when it was recently announced that the company entered into a $5b accelerated share repurchase ...

15:11 03/02/2017 Pfizer May Be Another IBM
Pfizer May Be Another IBM
Seeking Alpha - Feb 3, 2017
The stock trades near 30X earnings as if it were about to rebound with great growth. Yet, instead it just may be a lumbering giant making weak decisions not designed to provide rapid organic growth.

12:16 31/01/2017 Pfizer swings to 4Q profit after rough year, hikes 2017 view
Pfizer swings to 4Q profit after rough year, hikes 2017 view
The Seattle Times - Jan 31, 2017
FILE - In this Monday, Nov. 23, 2015, file photo, a woman passes Pfizer's world headquarters, in New York. Pfizer Inc. (PFE) on Tuesday, Jan. 31, 2017, reported fourth-quarter net income of $775 million, after reporting a loss in the same period a year ...
Pfizer's profit misses as vaccine sales lag, costs rise - CNBC
Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for February 01, 2017 - Nasdaq

19:41 27/01/2017 Could Pfizer now be a better pick for investors than Johnson & Johnson?
Could Pfizer now be a better pick for investors than Johnson & Johnson?
Motley Fool - Jan 27, 2017
Probably the best investing argument for Pfizer is that it appears to be effectively using its capital to position the company for long-term growth. It's no secret that Pfizer's legacy established products business is struggling, primarily because of ...

1:56 27/01/2017 Earnings Preview: What To Expect From Pfizer
Earnings Preview: What To Expect From Pfizer
Forbes - Jan 27, 2017
Pfizer Inc ($PFE) is scheduled to release earnings before Tuesday's open. The pharmaceutical giant hit a record high of $49.99 in 1999 and is currently trading near $31/share.

16:52 21/01/2017 How Will Pfizer Inc. Fare Under President Trump?
How Will Pfizer Inc. Fare Under President Trump?
Motley Fool - Jan 21, 2017
In 2015, Pfizer received Medicare payments of roughly $2.7 billion for Lyrica and Prevnar. That comprised less than 5.5% of the company's total revenue. Pfizer didn't own Xtandi until it acquired Medivation last year. Medicare shelled out around $791 ...